Food, Beverage & Tobacco Healthcare Sector

Palvella Therapeutics

Market Cap: US$261.9m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases.

Healwell AI

Market Cap: CA$351.5m

A healthcare artificial intelligence company, develops and commercializes clinical decision support systems in Canada, New Zealand, Australia, and the United Kingdom.

Inozyme Pharma

Market Cap: US$255.7m

A clinical-stage biopharmaceutical company, develops therapeutics for rare diseases that affect bone health and blood vessel function.

Vanda Pharmaceuticals

Market Cap: US$255.2m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

Mayne Pharma Group

Market Cap: AU$391.6m

A specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.

Alpha Tau Medical

Market Cap: US$254.1m

A clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer.

Health Catalyst

Market Cap: US$254.0m

Provides data and analytics technology and services to healthcare organizations in the United States.

Viemed Healthcare

Market Cap: US$253.7m

Through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States.

AirSculpt Technologies

Market Cap: US$249.8m

Focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom.

Verano Holdings

Market Cap: CA$341.7m

Operates as a vertically integrated multi-state cannabis operator in the United States.

Lifecore Biomedical

Market Cap: US$248.8m

Operates as an integrated contract development and manufacturing organization in the United States.

Tristel

Market Cap: UK£183.7m

Develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally.

Atea Pharmaceuticals

Market Cap: US$248.2m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections.

Neurogene

Market Cap: US$246.4m

A clinical stage biotechnology company, develops genetic medicines for rare neurological diseases.

Monte Rosa Therapeutics

Market Cap: US$244.2m

A clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically relevant proteins.

SANUWAVE Health

Market Cap: US$244.1m

Operates as a medical device company in the United States and internationally.

ADC Therapeutics

Market Cap: US$241.0m

Provides antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid tumors.

Tevogen Bio Holdings

Market Cap: US$240.9m

A clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders.

Tenax Therapeutics

Market Cap: US$240.1m

A clinical-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States.

Lexicon Pharmaceuticals

Market Cap: US$239.7m

A biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease.

Silence Therapeutics

Market Cap: US$239.0m

A biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

Cerus

Market Cap: US$239.0m

Operates as a biomedical products company.

MaxCyte

Market Cap: UK£176.0m

A life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.

Cartesian Therapeutics

Market Cap: US$237.7m

A clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases.

Animalcare Group

Market Cap: UK£175.2m

Develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets.

Creative Medical Technology Holdings

Market Cap: US$237.0m

A commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.

Rezolute

Market Cap: US$235.5m

A late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States.

Third Harmonic Bio

Market Cap: US$233.8m

A biopharmaceutical company, focuses on the development of the medicine for the treatment of dermal, respiratory, and gastrointestinal inflammatory diseases.

Aquestive Therapeutics

Market Cap: US$233.4m

Operates as a pharmaceutical company in the United States and internationally.

Nuvectis Pharma

Market Cap: US$232.3m

A clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.

Allogene Therapeutics

Market Cap: US$231.9m

A clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases.

Cipher Pharmaceuticals

Market Cap: CA$318.1m

Operates as a specialty pharmaceutical company in Canada.

Annexon

Market Cap: US$231.5m

A clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.

ZimVie

Market Cap: US$231.2m

Develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide.

Foghorn Therapeutics

Market Cap: US$230.8m

A clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States.

Dimerix

Market Cap: AU$354.4m

A biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia.